BioPharmaTrend
News
All Topics
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech
  • Interviews
  • Business Intelligence
  • Case Studies
Intelligence
  • Business Intelligence
  • Case Studies
  • Lab
  • Membership
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Newsletter
Login/Join
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech

  Next-Gen Tools

AI and Cryo-EM: A Powerful Alliance for Unraveling Biological Mysteries

by Halyna Buvailo, PhD  (contributor )   •   updated on Dec. 4, 2025

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email

As we advance further into the territories of biotechnology, the convergence of artificial intelligence (AI) and cryo-electron microscopy (Cryo-EM) has emerged as a powerful partnership for unlocking complex biological structures. In this blog post, we'll explore how AI is enabling Cryo-EM, enhancing our understanding of molecular architecture, and accelerating drug discovery. We'll also spotlight some pioneering companies developing Cryo-EM technology, and integrating AI to transform the field.

#advertisement
Pharma Complience Management: A UK/EU Guide

Unraveling the AI and Cryo-EM Connection

Cryo-EM is a cutting-edge microscopy technique that allows to freeze a biological sample, image it with electrons, and reconstruct a 3D map without growing crystals. The hard part is data scale and noise. Recent reviews describe stronger denoising methods and a shift toward deep learning as the default for early processing. This matters because cleaner inputs generally lead to better 3D maps. 

Lately, AI tools have been getting built into most steps of cryo-EM—spotting particles in noisy images, cleaning those images, checking quality during data collection, and turning maps into atomic models. New camera hardware and faster software cut analysis time and raise usable resolution, which helps teams decide earlier whether a sample is good enough to pursue.

Particle picking has become less manual. Self-supervised approaches learn from the data itself and remove the need for hand-labeled examples, which helps generalize to new samples and cell extracts. Model building has also moved on: instead of only fitting AlphaFold predictions into density, newer pipelines combine AI with the EM map to trace backbones at mid-resolution and to place ligands with better agreement to the observed density.

Notable Players in the Cryo-EM and AI Space

Thermo Fisher Scientific

Thermo Fisher sells a layered cryo-EM stack that runs from screening to high-throughput structure work: Tundra for entry-level studies, Glacios 2 for routine high-resolution work, and Krios G4/5 for the most demanding projects. These systems are transmission electron microscopes designed specifically for cryo-EM.

The data is captured through Falcon 4i which supports electron-event representation (EER), a file format that stores each detected electron hit with its time and position. That lets labs compress data efficiently and “re-bin” exposures later without losing detail—useful for motion correction and dose management. EER can be enabled directly in Thermo Fisher’s acquisition software.

The software, Smart EPU, automates grid screening and data collection for single-particle analysis, using AI-based plugins to rank targets, check ice quality and adjust settings in real time. Many facilities run live processing alongside collection so operators can decide during the session whether a sample is worth pushing to full-scale runs.


RELION

RELION  (REgularized LIkelihood OptimizatioN) is an open-source software suite used to turn raw cryo-EM images into 3D structures. It wraps most steps after data collection—2D/3D classification, refinement, map sharpening, and now a full subtomogram averaging path—under one Bayesian framework, which helps control overfitting and gives reproducible results across large datasets. Developed at the MRC Laboratory of Molecular Biology, it remains widely used alongside other pipelines.

Recent update includes: 

  • Blush regularisation—uses a denoising CNN inside refinement to stabilize weak-signal datasets; reported successful refinement of a ~40 kDa complex that failed with standard settings.
  • DynaMight—a variational autoencoder that models continuous motions, then “un-warps” them to improve the consensus map.
  • ModelAngelo integration—machine-learning model building for maps ≥3.5–4.0 Å.
  • Broader GPU support—added acceleration paths for AMD (HIP/ROCm) and Intel (SYCL) in addition to NVIDIA/CUDA.

RELION can read Falcon 4/4i electron-event representation (EER) movies and provides tools for conversion and practical settings, which is relevant for facilities using Thermo Fisher cameras. 


CryoSPARC

Developed by Structura Biotechnology, CryoSPARC is a software platform that turns raw cryo-EM images into 3D structures with a web interface most labs can run on their GPU workstations. It covers the full workflow—motion correction, particle picking, 2D/3D classification, refinement, and map assessment—and adds live processing so teams can judge data quality during collection rather than after. 

CryoSPARC includes tools for conformational heterogeneity—3D Variability Analysis (linear subspace model) and 3D Flexible Refinement (3DFlex), a motion-based neural-network model that “un-warps” continuous motions to sharpen the consensus map. 

Public release notes highlight the recent v4.x line with GPU performance boosts and UI responsiveness improvements, alongside the cryosparc-tools Python API for scripting and integration. Smart EPU+Embedded CryoSPARC Live is now a supported acquisition–analysis pairing on Thermo Fisher microscopes. 


Topaz

Topaz is an open-source AI toolkit that handles two pain points in cryo-EM: particle picking and denoising. Its picker uses positive-unlabeled learning, which lets a neural network learn from a small set of hand-picked particles and many unlabeled examples—cutting the amount of manual labeling needed while maintaining accuracy. 

The user can train a model on their dataset and auto-pick particles at scale; a companion module, Topaz-Denoise, provides learned denoising for micrographs and tomograms to improve downstream alignment and classification. The package runs on GPU workstations and is actively maintained.

Topaz plugs into common pipelines—RELION 4.x includes an integrated Topaz wrapper for auto-picking, and the official docs cover use with RELION and CryoSPARC. Labs also share step-by-step notes for pairing Topaz with these suites. 


crYOLO

crYOLO is an open-source deep-learning tool for particle picking in cryo-EM, built on the YOLO object-detection framework and developed in the SPHIRE ecosystem at the Max Planck Institute in Dortmund.

YOLO is a “one-stage” object-detection method that turns object finding into a single neural-network pass: it divides an image into a grid and, for each grid cell, directly predicts bounding boxes and confidence scores and class labels. No separate proposal stage. This design makes YOLO fast while remaining accurate.

crYOLO adapts YOLO for cryo-EM particle picking (usually a single class: “particle”). The user labels a small set of examples, trains briefly, then the network marks particle locations across micrographs at several images per second on a GPU. 

Labs can use crYOLO outputs with major pipelines (RELION, CryoSPARC) via standard coordinate export/import steps.


TomoTwin

TomoTwin is an open-source tool for finding proteins in cryo-electron tomograms using deep metric learning. It ships with pre-trained embeddings so users can localize targets without training a model from scratch.

A tomogram is the 3D image you get after recording a tilt-series of a frozen sample in the electron microscope and computationally reconstructing those 2D views into a volume—like a CT scan at the nanoscale. In cryo-electron tomography (cryo-ET), this lets you see molecules, organelles, and viruses in their native cellular context rather than averaged outside the cell. 

Single particle analysis (SPA) excels when you have many identical particles to average to near-atomic resolution; cryo-ET is chosen when heterogeneity and spatial context are the priority—unique assemblies, membrane organization, or interactions inside cells.

Two workflows are supported: a reference-based mode—provide one example of the protein of interest and the model searches the volume—and a de novo clustering mode that groups macromolecules on a 2D manifold to discover species without labels. Both are described in the original Methods paper.

In crowded, noisy cellular tomograms, TomoTwin reduces manual per-target training and accelerates particle localization for downstream subtomogram averaging or in-situ analysis.

Challenges in Cryo-EM and AI Integration

Despite the transformative impact of AI and Cryo-EM, several challenges remain. One significant hurdle is sample preparation. Getting thin, even vitreous ice and well-distributed particles is still hard. Blotting-based methods make ice thickness and particle distribution inconsistent; preferred orientation and air–water interface damage persist. Newer blot-free dispensers (e.g., Spotiton/Chameleon) and electrospray-assisted vitrification aim to reduce these effects but are not universal fixes. 

Sample heterogeneity can also hinder accurate analysis. Many specimens adopt multiple conformations and orientations. AI pickers and heterogeneity tools improve separation, yet benchmarks still flag difficult micrographs and mixed populations as failure points, especially at low SNR.

Another challenge lies in the computational requirements for Cryo-EM data processing. Raw movies frequently reach multi-terabyte scales per project; formats like Electron-Event Representation (EER) help by storing per-electron hits with flexible downstream binning, but still require high-throughput I/O. Cloud patterns like CryoSPARC on AWS with FSx/S3 are emerging options for labs without on-prem clusters.

The integration of AI also demands powerful hardware, high-performance GPUs, and substantial storage capacity. Many research institutions and smaller laboratories may lack the resources to fully harness AI's potential in Cryo-EM, which can limit their ability to analyze vast datasets efficiently.  

Read also: AI-powered Cryo-EM Attracts Big Bucks And Promises To Disrupt Structural Biology 

Additionally, as AI algorithms become more sophisticated, it is essential to ensure their transparency and reproducibility. The "black box" nature of some deep learning models can obscure the decision-making process, raising concerns about the validity and reliability of the results. Researchers must remain vigilant in validating AI-driven Cryo-EM findings, and the scientific community must work together to establish best practices and guidelines for AI integration in this field.

However, advancements are being made. Community archives now expect deposition of raw data (EMPIAR) alongside maps and models, enabling method validation and reprocessing; wwPDB/EMDB provide standardized EM validation reports and map-model quality metrics, with updated recommendations from recent workshops. These practices improve transparency for AI-assisted pipelines but don’t eliminate the need for case-by-case checks.

Topic: Next-Gen Tools

Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email

You may also be interested to read:

AI-powered Cryo-EM Attracts Big Bucks And Promises To Disrupt Structural Biology
by Natalia Honchar, Andrii Buvailo

 

#advertisement
Pharma Complience Management: A UK/EU Guide

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Newsletter
  • Business Intelligence
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Advertise
  • Lab Access
  • Lab Membership
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.